FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019591007> ?p ?o ?g. }

• W2019591007 endingPage "844" @default.
• W2019591007 startingPage "831" @default.
• W2019591007 abstract "Individuals with cancer have previously been shown to have abnormal chemotactic responsiveness. Surgical removal of the tumor often resulted in normalization of monocyte function, which suggests that human neoplasms might inhibit monocyte chemotaxis by release of soluble mediators. We therefore examined the effects of cancerous effusions on monocyte polarization, i.e., the rapid change in monocyte morphology from round to a triangular motile configuration in response to chemoattractants. All 17 malignant effusions, representing 15 tumor types, inhibited monocyte polarization induced by the chemoattractant N-formyl-methionyl-leucyl-phenylalanine by 45-89% (mean 55.9 +/- 12.7%, P less than 0.01) in blinded assays. None of 17 benign effusions signigicantly inhibited polarization (0-15%, mean 6.2 +/- 4.2%). Dilutions of cancerous effusions as low as 1:200 produced inhibition that was time, temperature, and dose dependent . Monocyte polarization induced by activated serum or by chemotactic lymphokine was also blocked by cancerous effusions. The inhibitory activity affected the monocyte directly, and did not destroy the chemoattractant or block the polarization of granulocytes to chemotactic factors. High pressure liquid chromatography of five cancerous fluids revealed three peaks of inhibitory activity: greater than or equal to 200,000, 46,000 +/- 13,000, and 21,000 +/- 3,000 daltons. Fractionation of noncancerous effusions revealed only small amounts of the highest molecular weight inhibitory activity. The inhibitory activity in cancerous effusion was heat stable (56 degrees C, 30 min), trypsin sensitive, and could be absorbed by three different monoclonal antibodies reactive to P15(E), a structural component of type C retroviruses. In contrast, six monoclonal antibodies with other specificities had no effect on the inhibitors of polarization. This study demonstrates that human cancerous effusions contain novel proteins that are potent inhibitors of monocyte function and that are recognized by antibodies reactive to the P15(E) component of retroviruses. By producing such factors, tumor cells may subvert monocyte-mediated surveillance." @default.
• W2019591007 created "2016-06-24" @default.
• W2019591007 creator A5020405246 @default.
• W2019591007 creator A5022023503 @default.
• W2019591007 creator A5048457926 @default.
• W2019591007 creator A5065526334 @default.
• W2019591007 creator A5076704294 @default.
• W2019591007 date "1981-10-01" @default.
• W2019591007 modified "2023-09-26" @default.
• W2019591007 title "Inhibitors of monocyte responses to chemotaxins are present in human cancerous effusions and react with monoclonal antibodies to the P15(E) structural protein of retroviruses." @default.
• W2019591007 cites W1519282484 @default.
• W2019591007 cites W1520164553 @default.
• W2019591007 cites W1547024869 @default.
• W2019591007 cites W1775749144 @default.
• W2019591007 cites W1943257944 @default.
• W2019591007 cites W1954055728 @default.
• W2019591007 cites W1970251727 @default.
• W2019591007 cites W1975747378 @default.
• W2019591007 cites W2016477899 @default.
• W2019591007 cites W2023913713 @default.
• W2019591007 cites W2025958411 @default.
• W2019591007 cites W2029515055 @default.
• W2019591007 cites W2040606873 @default.
• W2019591007 cites W2042038297 @default.
• W2019591007 cites W2050311365 @default.
• W2019591007 cites W2076940976 @default.
• W2019591007 cites W2089349175 @default.
• W2019591007 cites W2092680001 @default.
• W2019591007 cites W2097137141 @default.
• W2019591007 cites W2097908259 @default.
• W2019591007 cites W2101832508 @default.
• W2019591007 cites W2174417870 @default.
• W2019591007 cites W2260514675 @default.
• W2019591007 cites W2263417313 @default.
• W2019591007 cites W2291624521 @default.
• W2019591007 cites W2298577661 @default.
• W2019591007 cites W2338941426 @default.
• W2019591007 cites W2408451931 @default.
• W2019591007 cites W2409912500 @default.
• W2019591007 cites W2460658447 @default.
• W2019591007 cites W3111856753 @default.
• W2019591007 cites W4290168141 @default.
• W2019591007 cites W87082738 @default.
• W2019591007 cites W2404224047 @default.
• W2019591007 doi "https://doi.org/10.1172/jci110338" @default.
• W2019591007 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/370870" @default.
• W2019591007 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7026615" @default.
• W2019591007 hasPublicationYear "1981" @default.
• W2019591007 type Work @default.
• W2019591007 sameAs 2019591007 @default.
• W2019591007 citedByCount "116" @default.
• W2019591007 countsByYear W20195910072012 @default.
• W2019591007 countsByYear W20195910072014 @default.
• W2019591007 countsByYear W20195910072022 @default.
• W2019591007 crossrefType "journal-article" @default.
• W2019591007 hasAuthorship W2019591007A5020405246 @default.
• W2019591007 hasAuthorship W2019591007A5022023503 @default.
• W2019591007 hasAuthorship W2019591007A5048457926 @default.
• W2019591007 hasAuthorship W2019591007A5065526334 @default.
• W2019591007 hasAuthorship W2019591007A5076704294 @default.
• W2019591007 hasBestOaLocation W20195910071 @default.
• W2019591007 hasConcept C153911025 @default.
• W2019591007 hasConcept C159654299 @default.
• W2019591007 hasConcept C170493617 @default.
• W2019591007 hasConcept C185592680 @default.
• W2019591007 hasConcept C203014093 @default.
• W2019591007 hasConcept C2781184567 @default.
• W2019591007 hasConcept C54166955 @default.
• W2019591007 hasConcept C542903549 @default.
• W2019591007 hasConcept C55493867 @default.
• W2019591007 hasConcept C71924100 @default.
• W2019591007 hasConcept C86803240 @default.
• W2019591007 hasConceptScore W2019591007C153911025 @default.
• W2019591007 hasConceptScore W2019591007C159654299 @default.
• W2019591007 hasConceptScore W2019591007C170493617 @default.
• W2019591007 hasConceptScore W2019591007C185592680 @default.
• W2019591007 hasConceptScore W2019591007C203014093 @default.
• W2019591007 hasConceptScore W2019591007C2781184567 @default.
• W2019591007 hasConceptScore W2019591007C54166955 @default.
• W2019591007 hasConceptScore W2019591007C542903549 @default.
• W2019591007 hasConceptScore W2019591007C55493867 @default.
• W2019591007 hasConceptScore W2019591007C71924100 @default.
• W2019591007 hasConceptScore W2019591007C86803240 @default.
• W2019591007 hasIssue "4" @default.
• W2019591007 hasLocation W20195910071 @default.
• W2019591007 hasLocation W20195910072 @default.
• W2019591007 hasLocation W20195910073 @default.
• W2019591007 hasLocation W20195910074 @default.
• W2019591007 hasLocation W20195910075 @default.
• W2019591007 hasOpenAccess W2019591007 @default.
• W2019591007 hasPrimaryLocation W20195910071 @default.
• W2019591007 hasRelatedWork W1999686187 @default.
• W2019591007 hasRelatedWork W2024585522 @default.
• W2019591007 hasRelatedWork W2036604909 @default.
• W2019591007 hasRelatedWork W2051602839 @default.
• W2019591007 hasRelatedWork W2185190580 @default.
• W2019591007 hasRelatedWork W2368460920 @default.
• W2019591007 hasRelatedWork W2380360044 @default.

• next